Skip to main content
NBTX
NASDAQ Life Sciences

Nanobiotix Finalizes $100M Global Offering with Full Over-Allotment Exercise

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$41.01
Mkt Cap
$1.884B
52W Low
$3.64
52W High
$57.14
52W Position info
1027% above low
Off High info
28% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

NBTX has more than doubled off its 52-week low of $3.64.

Summary

Nanobiotix has completed its global offering, raising $100 million after underwriters fully exercised their over-allotment option, securing funding into 2029.


Key Events · Financing and Capital Events · NBTX

  • Offering Finalized

    Underwriters fully exercised their over-allotment option for the global offering, increasing the total capital raised.

  • Capital Raised

    The global offering, including the over-allotment, generated approximately $100 million in gross proceeds for the company.

  • Cash Runway Extended

    The company expects these proceeds, combined with existing cash, to fund operations into 2029.

  • Pricing Details

    The offering was priced at $38.98 per ADS, which represents a 14.92% discount to the volume-weighted average price of ordinary shares on Euronext Paris.


Analysis · NBTX · Life Sciences

This filing confirms the full exercise of the underwriters' over-allotment option, increasing the total gross proceeds from the global offering to $100 million. This capital raise, though dilutive and priced at a discount, significantly extends Nanobiotix's cash runway into 2029, providing crucial financial stability for its clinical development programs. The full exercise of the option indicates strong investor demand for the offering.

How filings like this one have moved

In the 30 days to Aug 26, 2026, 37.4% of the 3468 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NBTX was trading at $41.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $3.64 to $57.14. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NBTX - Latest Insights

NBTX
Jun 02, 2026, 4:32 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.76
Real-time Price: $41.51 info
Change: +$4.75 (+13%) info
Market Cap: $2.015B info
NBTX
Jun 02, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $36.76
Real-time Price: $41.51 info
Change: +$4.75 (+13%) info
Market Cap: $2.015B info
NBTX
May 26, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $40.80
Real-time Price: $41.51 info
Change: +$0.710 (+2%) info
Market Cap: $2.015B info
NBTX
May 26, 2026, 5:08 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $40.80
Real-time Price: $41.51 info
Change: +$0.710 (+2%) info
Market Cap: $2.015B info
NBTX
May 26, 2026, 4:44 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $40.80
Real-time Price: $41.51 info
Change: +$0.710 (+2%) info
Market Cap: $2.015B info